Westchester, Ill. –A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine suggests that screening type 2 diabetes patients for obstructive sleep apnea (OSA) and treating those who have OSA with continuous positive airway pressure (CPAP) therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis.
Results show that in a group of 20 type 2 diabetics who were mostly obese and were newly diagnosed... read more
Submitted by Avera
A new study from the CDC projects that the number of adults 40 and older with diabetic retinopathy, the leading cause of blindness among working-age adults, will reach 16 million in 2050, up from 5.5 million in 2005. Diabetics are also more prone to developing cataracts and glaucoma, the study notes, and older Latinos and blacks are expected to be disproportionately affected.
Submitted by Avera
Pregnant women with gum disease beware: You’re at risk of developing gestational diabetes. The condition develops during pregnancy and usually ebbs after the baby is born, but it can increase your chances of developing type 2 diabetes later on. According to one study, pregnant women who developed gestational diabetes had high levels of gum disease-causing bacteria and inflammation. Researchers speculate that gum disease may impair blood sugar control, leading to the development of diabetes. Published... read more
Submitted by Gabby
You know about stomach ulcers, but foot ulcers? That’s right: You can get an ulcer on your foot. Some diabetics, both type 1 and type 2, encounter painful, red sores shaped like a crater that ooze pus and emit a foul-smelling discharge. Foot ulcers occur in high-pressure areas, most commonly found on the bottom or side of the big toe and on the ball of the foot, especially under the big toe joint. The break... read more
Submitted by Gabby
RESEARCH TRIANGLE PARK, NC, Dec 12, 2008 (MARKET WIRE via COMTEX) -- A new drug class is poised to make a splash in the diabetes market, according to a new report, "Diabetes Market Forecast to 2013" ( http://www.cuttingedgeinfo.com/Diabetes/ index.htm#body), published by Cutting Edge Information. SGLT2 Inhibitors, which block the reabsorption of glucose in the kidneys, have had positive clinical results and have attracted the attention of top pharmaceutical companies. While no SGLT2 inhibitor is currently... read more
Submitted by Avera
PHILADELPHIA, Dec 09, 2008 /PRNewswire-USNewswire via COMTEX/ -- Overweight siblings of children with type 2 diabetes are four times more likely to have abnormal glucose levels compared to other overweight children. Because abnormal glucose levels may indicate risk for diabetes or diabetes itself, these children could benefit from screening tests and diabetes prevention education.
Researchers from The Children's Hospital of Philadelphia published their findings today in the online edition of the Journal of Pediatrics.... read more
Submitted by Avera
Byetta, a drug commonly prescribed for the treatment of type 2 (adult onset) diabetes, has been linked to an increased risk of deadly pancreatic disease. Dozens of Byetta patients have suffered a painful injury called hemorrhagic pancreatitis, or inflammation of the pancreas, that resulted in death or serious injuries. The Food and Drug Administration has issued several public advisories about Byetta’s connection to pancreatic disease and warned users about the risk.
FDA Issues Warnings... read more
Submitted by Avera
TUESDAY, Dec. 9 (HealthDay News) -- The number of Americans with diabetic retinopathy is expected to increase from 5.5 million to 16 million by the year 2050, according to a U.S. Centers for Disease Control and Prevention study.
Diabetic retinopathy, which is damage to the small blood vessels in the retina, is the leading cause of blindness among working-age adults in the United States. In 2004, about $500 million was spent on direct medical... read more
Submitted by Avera
Is there a link between sleep and type 2 diabetes? That's one implication of a new study, which has found that variants in a gene that helps regulate the body's daily rhythms increase the chance of developing the disease. The find, reported online yesterday in three papers in Nature Genetics, may suggest new ways to treat or prevent the ever more common disorder.
The body's internal clock--or circadian rhythm--is kept accurate by a hormone... read more
Submitted by Avera
REYKJAVIK, Iceland, Dec 08, 2008 /PRNewswire-FirstCall via COMTEX/ -- deCODE genetics (DCGN:decode genetics inc com
News, chart, profile, more
Last: 0.24-0.01-4.00%
3:57pm 12/08/2008
Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
DCGN 0.24, -0.01, -4.0%) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the human... read more
Submitted by Avera